US2015342499A1PendingUtilityA1
Opacity technology
Assignee: QUALIMED INNOVATIVE MED PRODPriority: Jul 6, 2010Filed: Jul 22, 2015Published: Dec 3, 2015
Est. expiryJul 6, 2030(~3.9 yrs left)· nominal 20-yr term from priority
Inventors:Eric K. Mangiardi
A61M 25/10A61B 5/065A61B 6/481A61M 2025/1079A61M 5/007A61M 25/0017A61M 25/0108A61M 2025/105A61M 2039/229A61M 39/22A61B 2090/3966A61M 25/104A61B 90/39A61K 49/22A61K 49/04A61K 49/00A61B 2090/3954A61K 49/06
53
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A catheter device comprising a chamber containing an opacity enhancing substance is disclosed. The opacity enhancing substance is in a dried or semi-dried form within the chamber of the device. Release of a liquid into the chamber suspends the substance and forms an opacity enhancing solution that is released into the lumen of the device in order to enhance the opacity of the device for imaging.
Claims
exact text as granted — not AI-modified1 . A catheter device comprising:
an elongated catheter body having a proximal end and distal end and a conduit within the catheter body; and a mixing chamber at the proximal end of the catheter body; wherein the mixing chamber is in fluid communication with the conduit, wherein the mixing chamber is configured to allow an opacity enhancing substance in the mixing chamber to be suspended, dissolved or diluted with a liquid to form an opacity enhancing liquid.
2 . The catheter device of claim 1 , wherein the mixing chamber further comprises an opacity enhancing substance.
3 . The catheter device of claim 2 , wherein the opacity enhancing substance is in a dried, semidried or concentrated liquid form.
4 . The catheter device of claim 2 , wherein opacity enhancing substance is adhered to the inner surface of the chamber.
5 . The catheter device of claim 1 , wherein the mixing chamber further comprises a membrane or screen that separate the mixing chamber into two or more sections.
6 . The catheter device of claim 1 , wherein the catheter device further comprises a balloon at the distal end, wherein the balloon is in fluid communication with the mixing chamber through the conduit.
7 . The catheter device of claim 2 , wherein the mixing chamber further comprises a second port for receiving the opacity enhancing substance.
8 . The catheter device of claim 2 , wherein the mixing chamber is configured to create a turbulent flow to mix the opacity enhancing substance with the liquid.
9 . The catheter device of claim 2 , wherein the opacity enhancing substance is selected from the group consisting of iodine compounds, barium sulfate, barium iridium, iron particles, tungsten, fluorescent dyes, gadolinium, and microbubbles.
10 . The catheter device of claim 9 , wherein the iodine compound is an ionic iodine compound or a nonionic iodine compound.
11 . The catheter device of claim 10 , wherein the ionic iodine compound is selected from the group consisting of diatrizoic acid, metrizoic acid, ioglicic acid, or salts thereof.
12 . The catheter device of claim 10 , wherein the non-ionic iodine compound is selected from the group consisting of iopadimol, iohexol, ioxilan, iopromide, and iodixanol.
13 . The catheter device of claim 1 , wherein the catheter is selected from the group consisting of balloon catheters, vascular catheters, cardiac catheters, arterial catheters, venous catheters, neurovascular catheters, intestinal catheters, esophageal catheters, urinary catheters, and Foley catheters.
14 . The catheter device of claim 1 , wherein the catheter device further comprises a stent at the distal end of the catheter body.
15 . The catheter device of claim 2 , wherein the mixing chamber is configured to receive a removable and replaceable cartridge containing the opacity enhancing material.
16 - 27 . (canceled)Join the waitlist — get patent alerts
Track US2015342499A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.